Speciality Medicines IPO Day 2 Subscription Status at 0.82x So far
By HDFC SKY | Published at: Mar 23, 2026 11:36 AM IST
Speciality Medicines IPO subscribed 0.82 times as of Day 2 so far, led by NII demand
Mumbai, March 23: Speciality Medicines IPO, a ₹29.14 crore book-built issue, is scheduled to close on March 24, 2026. The price band for the issue which opened for subscription on March 20, 2026 and is set at ₹117 to ₹124 per share, with a lot size of 1,000 shares.
The public issue is entirely a fresh issue of 23.50 lakh shares and will be listed on the BSE SME platform. The basis of allotment is expected to be finalised on March 25, 2026, with a tentative listing date of March 30, 2026.
Speciality Medicines IPO Day 2 Subscription Status
As of March 23, 2026 at 10:49:41 AM (Day 2), the Speciality Medicines IPO has been subscribed 0.82 times overall.
Category-wise Speciality Medicines IPO Subscription Status
| Category | Subscription (x) | Shares Offered | Shares Bid For |
| QIB (Ex Anchor) | 1.00 | 21,000 | 21,000 |
| NII (HNI) | 1.53 | 10,89,000 | 16,61,000 |
| bNII (> ₹10L) | 2.25 | 7,26,000 | 16,36,000 |
| sNII (< ₹10L) | 0.07 | 3,63,000 | 25,000 |
| Retail Investors | 0.11 | 10,90,000 | 1,18,000 |
| Total | 0.82 | 22,00,000 | 18,00,000 |
Speciality Medicines Day’s Wise Subscription Summary
| Date | QIB (Ex Anchor) | NII | bNII (> ₹10L) | sNII (< ₹10L) | Retail | Total |
| March 20 (Day 1) | 1.00 | 1.60 | 2.37 | 0.06 | 0.07 | 0.84 |
| March 23 (Day 2) | 1.00 | 1.53 | 2.25 | 0.07 | 0.11 | 0.82 |
Speciality Medicines IPO Timeline
| Event | Date |
| Issue Open Date | March 20 2026 |
| Issue Close Date | March 24 2026 |
| Basis of Allotment | March 25 2026 |
| Initiation of Refunds | March 27 2026 |
| Credit of Shares | March 27 2026 |
| Listing Date | March 30 2026 |
Brief Overview Of The IPO
Speciality Medicines IPO is a ₹29.14 crore issue comprising a fresh issue of 23,50,000 shares. The price band is fixed at ₹117 to ₹124 per share. Investors can bid in lots of 1,000 shares, translating to a minimum investment of ₹2,48,000 at the upper price band.
Incorporated in 2021, Speciality Medicines Limited operates in the marketing and distribution of speciality pharmaceutical formulations, including treatments for chronic and complex conditions across domestic and international markets. The company offers a diverse portfolio spanning tablets, injectables, capsules, and other dosage formats.
Source:
https://www.bseindia.com/markets/publicIssues/DisplayIPO.aspxid=4512&type=IPO&idtype=1&status=L&IPONo=7653&startdt=20/Mar/2026
Disclaimer
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations
